IntegraGen S.A.
ALINT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €3,290 | €3,795 | €3,564 | €5,890 |
| - Cash | €1,679 | €1,900 | €862 | €1,834 |
| + Debt | €417 | €643 | €869 | €1,125 |
| Enterprise Value | €2,028 | €2,538 | €3,572 | €5,180 |
| Revenue | €2,564 | €4,101 | €4,570 | €6,484 |
| % Growth | -37.5% | -10.3% | -29.5% | – |
| Gross Profit | -€1,461 | €2,267 | -€481 | €2,697 |
| % Margin | -57% | 55.3% | -10.5% | 41.6% |
| EBITDA | -€1,419 | -€1,787 | -€120 | €167 |
| % Margin | -55.3% | -43.6% | -2.6% | 2.6% |
| Net Income | -€1,407 | -€140 | -€115 | €91 |
| % Margin | -54.9% | -3.4% | -2.5% | 1.4% |
| EPS Diluted | -0.21 | -0.021 | -0.017 | 0.014 |
| % Growth | -904.8% | -22.2% | -223.9% | – |
| Operating Cash Flow | -€646 | €0 | €0 | €0 |
| Capital Expenditures | -€1 | €0 | €0 | €0 |
| Free Cash Flow | -€646 | €0 | €0 | €0 |